Portugal Pharmaceutical Market Forecast

It is BMI's view that the slowdown in drug market growth in Portugal in recent years will continue in 2010, with drug sales expected to reach a value of EUR3.64bn (US$5.27bn), equating to growth of 0.40% in local currency terms and 3.29% in US dollar terms. We attribute this to the continued effect of the country's poor fiscal status and the possibility of further drug price cuts aimed at generating much needed savings.

To read the full article, please choose one of the following options: